MDFGX
Price
$38.73
Change
-$0.07 (-0.18%)
Updated
Dec 3 closing price
Net Assets
3.82B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

MDFGX vs VIGRX

Header iconMDFGX vs VIGRX Comparison
Open Charts MDFGX vs VIGRXBanner chart's image
BlackRock Capital Appreciation Inv A
Price$38.73
Change-$0.07 (-0.18%)
VolumeN/A
Net Assets3.82B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
MDFGX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
MDFGX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDFGX is a StrongBuy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. MDFGX (3.82B). VIGRX pays higher dividends than MDFGX: VIGRX (0.30) vs MDFGX (0.00). MDFGX was incepted earlier than VIGRX: MDFGX (28 years) vs VIGRX (33 years). MDFGX (0.97) is less costly to investors than VIGRX (0.17). MDFGX is a more actively managed with annual turnover of: 29.00 vs. VIGRX (11.00). MDFGX has a lower initial minimum investment than VIGRX: MDFGX (1000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. MDFGX (-0.92). VIGRX return over 5 years is better than : 99.11 vs. MDFGX (3.14).
MDFGXVIGRXMDFGX / VIGRX
Total Expense Ratio0.920.17541%
Annual Report Gross Expense Ratio0.970.17571%
Fund Existence28 years33 years-
Gain YTD4.64719.76424%
Front Load5%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets3.82B357B1%
Annual Yield % from dividends0.000.30-
Returns for 1 year-0.9218.49-5%
Returns for 3 years57.18110.8252%
Returns for 5 years3.1499.113%
Returns for 10 years47.77349.1314%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT